Name: trabectedin
Brand: YONDELIS

Which patents cover Yondelis, and what generic Yondelis alternatives are available?

Yondelis is a drug marketed by Janssen Prods and is included in one NDA. There is one patent protecting this drug.

This drug has thirty-nine patent family members in thirty-five countries.

The generic ingredient in YONDELIS is trabectedin. There are four drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the trabectedin profile page.

Summary for Tradename: YONDELIS

Patents:	1
Applicants:	1
NDAs:	1
Suppliers / Packagers: see list	1
Bulk Api Vendors: see list	16
Clinical Trials: see list	40
Patent Applications: see list	10
Drug Prices:	see details
DailyMed Link:	YONDELIS at DailyMed

Pharmacology for Tradename: YONDELIS

Drug Class	Alkylating Drug
Mechanism of Action	Alkylating Activity

ADD ALERT

Glossary

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Type	RLD	RS	Patent No.	Patent Expiration	Product	Exclusivity Expiration
Janssen Prods	YONDELIS	trabectedin	POWDER;IV (INFUSION)	207953-001	Oct 23, 2015	RX	Yes	Yes	► Subscribe	► Subscribe	Y	► Subscribe
Janssen Prods	YONDELIS	trabectedin	POWDER;IV (INFUSION)	207953-001	Oct 23, 2015	RX	Yes	Yes	► Subscribe	► Subscribe		► Subscribe
Janssen Prods	YONDELIS	trabectedin	POWDER;IV (INFUSION)	207953-001	Oct 23, 2015	RX	Yes	Yes	► Subscribe	► Subscribe		► Subscribe

This preview shows a limited data set Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Tradename: YONDELIS

Country	Document Number	Estimated Expiration
Serbia	50510	► Subscribe
Japan	2006124393	► Subscribe
Denmark	1658848	► Subscribe
Norway	20072713	► Subscribe
Malaysia	139049	► Subscribe

This preview shows a limited data set Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

DrugPatentWatch Database Preview

YONDELIS Drug Profile

« Back to Dashboard